Treatment with JQ1, a BET bromodomain inhibitor, is selectively detrimental to R6/2 Huntington's disease mice.
Title: | Treatment with JQ1, a BET bromodomain inhibitor, is selectively detrimental to R6/2 Huntington's disease mice. |
---|---|
Authors: | Kedaigle, Amanda J, Reidling, Jack C, Lim, Ryan G, Adam, Miriam, Wu, Jie, Wassie, Brook, Stocksdale, Jennifer T, Casale, Malcolm S, Fraenkel, Ernest, Thompson, Leslie M |
Source: | Human Molecular Genetics; 1/15/2020, Vol. 29 Issue 2, p202-215, 14p |
Database: | Complementary Index |
ISSN: | 09646906 |
---|---|
DOI: | 10.1093/hmg/ddz264 |
Published in: | Human Molecular Genetics |
Language: | English |